% alzhub.org topic: cholinesterase-inhibitors
% Source: https://alzhub.org/topic/cholinesterase-inhibitors
% 17 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{haake2020-31976781,
  author  = {Haake, A. and Nguyen, K. and Friedman, L. and Chakkamparambil, B. and Grossberg, G. T.},
  title   = {{An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease}},
  journal = {Expert opinion on drug safety},
  year    = {2020},
  doi     = {10.1080/14740338.2020.1721456},
  pmid    = {31976781},
  url     = {https://doi.org/10.1080/14740338.2020.1721456}
}

@article{dou2018-30591071,
  author  = {Dou, K. X. and Tan, M. S. and Tan, C. C. and Cao, X. P. and Hou, X. H. and Guo, Q. H. and Tan, L. and Mok, V. and others},
  title   = {{Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0457-9},
  pmid    = {30591071},
  url     = {https://doi.org/10.1186/s13195-018-0457-9}
}

@article{li2018-30243151,
  author  = {Li, Q. and He, S. and Chen, Y. and Feng, F. and Qu, W. and Sun, H.},
  title   = {{Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease}},
  journal = {European journal of medicinal chemistry},
  year    = {2018},
  doi     = {10.1016/j.ejmech.2018.09.031},
  pmid    = {30243151},
  url     = {https://doi.org/10.1016/j.ejmech.2018.09.031}
}

@article{blancosilvente2017-28201726,
  author  = {Blanco-Silvente, L. and Castells, X. and Saez, M. and Barceló, M. A. and Garre-Olmo, J. and Vilalta-Franch, J. and Capellà, D.},
  title   = {{Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients}},
  journal = {The international journal of neuropsychopharmacology},
  year    = {2017},
  doi     = {10.1093/ijnp/pyx012},
  pmid    = {28201726},
  url     = {https://doi.org/10.1093/ijnp/pyx012}
}

@article{ali2015-26642212,
  author  = {Ali, T. B. and Schleret, T. R. and Reilly, B. M. and Chen, W. Y. and Abagyan, R.},
  title   = {{Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0144337},
  pmid    = {26642212},
  url     = {https://doi.org/10.1371/journal.pone.0144337}
}

@article{nordstrom2013-23735859,
  author  = {Nordström, P. and Religa, D. and Wimo, A. and Winblad, B. and Eriksdotter, M.},
  title   = {{The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease}},
  journal = {European heart journal},
  year    = {2013},
  doi     = {10.1093/eurheartj/eht182},
  pmid    = {23735859},
  url     = {https://doi.org/10.1093/eurheartj/eht182}
}

@article{tayeb2012-22198801,
  author  = {Tayeb, H. O. and Yang, H. D. and Price, B. H. and Tarazi, F. I.},
  title   = {{Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors}},
  journal = {Pharmacology \& therapeutics},
  year    = {2012},
  doi     = {10.1016/j.pharmthera.2011.12.002},
  pmid    = {22198801},
  url     = {https://doi.org/10.1016/j.pharmthera.2011.12.002}
}

@article{musial2007-17979717,
  author  = {Musiał, A. and Bajda, M. and Malawska, B.},
  title   = {{Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment}},
  journal = {Current medicinal chemistry},
  year    = {2007},
  doi     = {10.2174/092986707782023217},
  pmid    = {17979717},
  url     = {https://doi.org/10.2174/092986707782023217}
}

@article{gill2005-15824303,
  author  = {Gill, S. S. and Mamdani, M. and Naglie, G. and Streiner, D. L. and Bronskill, S. E. and Kopp, A. and Shulman, K. I. and Lee, P. E. and others},
  title   = {{A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs}},
  journal = {Archives of internal medicine},
  year    = {2005},
  doi     = {10.1001/archinte.165.7.808},
  pmid    = {15824303},
  url     = {https://doi.org/10.1001/archinte.165.7.808}
}

@article{wang2005-15956816,
  author  = {Wang, R. and Tang, X. C.},
  title   = {{Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease}},
  journal = {Neuro-Signals},
  year    = {2005},
  doi     = {10.1159/000085387},
  pmid    = {15956816},
  url     = {https://doi.org/10.1159/000085387}
}

@article{loewenstein2004-15249277,
  author  = {Loewenstein, D. A. and Acevedo, A. and Czaja, S. J. and Duara, R.},
  title   = {{Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2004},
  doi     = {10.1176/appi.ajgp.12.4.395},
  pmid    = {15249277},
  url     = {https://doi.org/10.1176/appi.ajgp.12.4.395}
}

@article{cummings2003-12611743,
  author  = {Cummings, J. L.},
  title   = {{Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2003},
  doi     = {10.1097/00019442-200303000-00004},
  pmid    = {12611743},
  url     = {https://doi.org/10.1097/00019442-200303000-00004}
}

@article{coyle2001-11230880,
  author  = {Coyle, J. and Kershaw, P.},
  title   = {{Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease}},
  journal = {Biological psychiatry},
  year    = {2001},
  doi     = {10.1016/s0006-3223(00)01101-x},
  pmid    = {11230880},
  url     = {https://doi.org/10.1016/s0006-3223(00)01101-x}
}

@article{grutzendler2001-11217870,
  author  = {Grutzendler, J. and Morris, J. C.},
  title   = {{Cholinesterase inhibitors for Alzheimer's disease}},
  journal = {Drugs},
  year    = {2001},
  doi     = {10.2165/00003495-200161010-00005},
  pmid    = {11217870},
  url     = {https://doi.org/10.2165/00003495-200161010-00005}
}

@article{ogura2000-11256231,
  author  = {Ogura, H. and Kosasa, T. and Kuriya, Y. and Yamanishi, Y.},
  title   = {{Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro}},
  journal = {Methods and findings in experimental and clinical pharmacology},
  year    = {2000},
  doi     = {10.1358/mf.2000.22.8.701373},
  pmid    = {11256231},
  url     = {https://doi.org/10.1358/mf.2000.22.8.701373}
}

@article{cacabelos2000-12861345,
  author  = {Cacabelos, R. and Alvarez, A. and Lombardi, V. and Fernández-Novoa, L. and Corzo, L. and Pérez, P. and Laredo, M. and Pichel, V. and others},
  title   = {{Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics}},
  journal = {Drugs of today (Barcelona, Spain : 1998)},
  year    = {2000},
  pmid    = {12861345}
}

@article{giacobini1998-9676739,
  author  = {Giacobini, E.},
  title   = {{Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications}},
  journal = {Neurochemistry international},
  year    = {1998},
  doi     = {10.1016/s0197-0186(97)00124-1},
  pmid    = {9676739},
  url     = {https://doi.org/10.1016/s0197-0186(97)00124-1}
}